• Explore /
  • Poster
  • / Study EV-104: Phase 1 study of intravesical enfortumab vedotin for treatment of patients with non-muscle invasive bladder cancer (NMIBC)—Trial in progress.

Study EV-104: Phase 1 study of intravesical enfortumab vedotin for treatment of patients with non-muscle invasive bladder cancer (NMIBC)—Trial in progress.

Abstract Poster

Authors

Ashish Kamat

Ashish M. Kamat

The University of Texas MD Anderson Cancer Center, Houston, TX

Ashish M. Kamat , Gary D. Steinberg , Brant Allen Inman , Max R. Kates , Edward M. Uchio , Sima P. Porten , Morgan Roupret , Joan Redorta , James W.F. Catto , Girish S. Kulkarni , Thomas Powles , Mark Tyson , Gabriel P. Haas , Yao Yu , Matthew Birrenkott , Yair Lotan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05014139

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr TPS582)

DOI

10.1200/JCO.2023.41.6_suppl.TPS582

Abstract #

TPS582

Poster Bd #

P5

Abstract Disclosures

Similar Posters

First Author: Ashish M. Kamat

First Author: Christopher J. Hoimes

First Author: David Samuel DiCapua Siegel

First Author: Igor Tsaur